Table 3. Patient outcomes in pre- and post-implementation groups
| Variables | Pre | Post | p value |
|---|---|---|---|
| ICU length (days), median (IQR) | 9.4 (4–15.5) | 7.3 (3.4–13.4) | 0.01** |
| Hospital length (days),a median (IQR) | 15.4 (8.4–25) | 12.6 (7.5–24.4) | 0.055* |
| ICU mortality, N (%) | 42 (14.4) | 50 (11.3) | 0.22** |
| Hospital mortality, N (%) | 42 (14.4) | 50 (11.3) | 0.22** |
| 28-day mortality,bN (%) | 47 (17.7) | 60 (17.6) | 0.98** |
| Catheter-associated central line infection, N (%) | 13 (2.93%) | 6 (1.2%) | 0.06** |
| Ventilator-associated events, N (%) | 146 (24.2%) | 194 (29%) | 0.054** |
| Catheter-associated urinary tract infections, N (%) | 5 (1.15%) | 11 (2.29%) | 0.19** |
| Pressure ulcer,cN (%) | 41 (2.89%) | 73 (3.69%) | 0.2** |
a
Hospital length unknown for 1 patient in pre-group and 14 patients in post-group.
b
Twenty-eight-day outcome unknown for 23 patients in pre-group and 102 patients in post-group.
c
Pressure ulcer observation days: pre = 1417 and post = 1976.
*
Mann–Whitney U-test.
**
Chi-square test.